Healthcare -
Biotechnology - NASDAQ - GB
$ 0.54
-2.01 %
$ 23 M
Market Cap
-3.18
P/E
ADAP - TOTAL CURRENT LIABILITIES
Total Current Liabilities ADAP - Adaptimmune Therapeutics plc
72.8 M
LAST VALUE
7.88%
2 YEAR CAGR
24.39%
5 YEAR CAGR
33.77%
10 YEAR CAGR